Skip to main content

Erratum to: Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: a real-world, retrospective, claims-based, comparative analysis

The Original Article was published on 25 March 2014

After the publication of this work [1], it was brought to our attention that a statement in the article is not consistent with the data. The statement “Prior RBC transfusions were found to significantly increase the time to hospitalization (adjusted HR 1.373, p = 0.018) while no other covariates examined were found to impact the risk of hospitalization” is not a correct reflection of the results from the data analysis in Table 2 of the article.

The corrected statement is provided here as follows:

“Prior RBC transfusions were found to significantly shorten the time to hospitalization (adjusted HR 1.373, p = 0.018) while no other covariates examined were found to impact the risk of hospitalization.”

References

  1. 1.

    Smith DB, Beach CL, Mahmoud D, Weber L, Henk HJ: Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: a real-world, retrospective, claims-based, comparative analysis. Exp Hematol Oncol 2014, 3: 10. 10.1186/2162-3619-3-10

    PubMed Central  PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Henry J Henk.

Additional information

B Douglas Smith, Dalia Mahmoud and Henry J Henk contributed equally to this work.

The online version of the original article can be found at 10.1186/2162-3619-3-10

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Smith, B.D., Beach, C.L., Mahmoud, D. et al. Erratum to: Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: a real-world, retrospective, claims-based, comparative analysis. Exp Hematol Oncol 3, 19 (2014). https://doi.org/10.1186/2162-3619-3-19

Download citation